A proven roadmap for innovation and commercialization
We empower inventors — paving pathways, clearing obstacles and dedicating significant resources to technology transfer.
Impact Dashboard
251
FY22 Invention Disclosures
79
FY22 U.S. Patents Issued
$14.6M
FY22 Licensing Revenue
7
FY22 New IP Based Startups
This is WashU Innovation
The Office of Technology Management assists WashU faculty in the transfer of technology from the lab to the global marketplace.
Explore our innovation community
Upcoming Events
A research powerhouse becomes an innovation incubator
“We believe in the idea that research can improve health outcomes, decrease health-care costs and improve the regional economy.” — David H. Perlmutter, MD, executive vice chancellor for medical affairs and the George and Carol Bauer Dean of the School of Medicine
In the news
World’s first nasal COVID-19 vaccine approved in India; based on Washington University technology
The world’s first nasal vaccine for COVID-19 was approved Tuesday, Sept. 6, in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University in St. Louis and developed in collaboration with Bharat Biotech International Limited in India.
New technology offers pathways to finding treatments for kidney disease
The search for effective treatments has been hampered because these highly structured cells cannot be cultured outside of the body, and because immortalized cell lines are not true to their structure. New research from Washington University’s McKelvey School of Engineering and the School of Medicine aims to overcome this critical barrier.
Biotech startup, which has raised more than $200M in VC funding, launches clinical trial for cancer drug
St. Louis-based clinical-stage biotechnology startup Wugen, which has raised more than $200 million in venture funding, has launched a clinical trial for one of its cancer-fighting therapies.
#WashUInnovators
A blood test developed at #WashUMed has proven highly accurate in detecting early signs of Alzheimer’s, even among patients not yet experiencing cognitive declines.
Announcements
University again named to top 100 patent list
Lishko named BJC Investigator
Resources for Students & Alumni
The Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship serves as the primary resource for students and alumni.